ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March

October 20, 1978

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

NCI Clarifies P01 Grant Application Dates

September 13, 1996